Other metabolic alterations that are observed to be related to colorectal cancer initiation are the overexpression of GLS1, GLUD1, and the mitochondrial aspartate glutamate carrier 2 (SLC25A13), which are associated with tumour growth and poorer outcome in colon cancer [93,95]. Here, SLC25A13 is linked to neoplasm.